After the middle of May this year, the price of honeysuckle dropped sharply, and the price of unified purchases dropped from about 300 yuan per kilogram to 150 yuan.
Earlier, the honeysuckle market has been bullish for two consecutive years and the market price has been on the rise. Many townships and towns in our province regard it as a key industry to adjust the income structure of farmers and give them strong support.
On October 15, the Hubei Honeysuckle Industry Development Seminar was held in Yangxin. Experts at the meeting said that the fall in the price of honeysuckle this time is a return to normal value, and the prospects for planting honeysuckle are still promising.
With comprehensive development potential Honeysuckle is a precious medicinal flower, its flowers, leaves, vines can be used as medicine. In recent years, honeysuckle has been identified by the State Council as one of the 70 kinds of valuable medicinal materials and one of the 38 kinds of precious Chinese medicinal materials that the country has focused on.
According to incomplete statistics, one-third of Chinese herbal formulas require the use of honeysuckle, such as the well-known "Yinqiao Tablets," "Yinhuang Oral Liquid," "Shuanghuanglian," etc., all with honeysuckle as the main raw material.
According to Shi Weidong, deputy general manager of Hubei Golden Eagle Agricultural Development Co., Ltd., honeysuckle has many functions, especially for enhancing immunity, cancer resistance, and regulating fat metabolism. It has become a health food and beverage for Wahaha honeysuckle tea and Wong Lo Kat herbal tea. Important raw materials. The fragrance extracted from honeysuckle has a market price of RMB 750,000 per kilogram. Currently, some companies have achieved initial results in purification technology.
Professor Zhang Chongyi of Henan Agricultural University pointed out that honeysuckle has been listed as the preferred medicine in the prevention and treatment prescriptions for "bird flu" and "hand-foot-mouth disease" in recent years. Many countries, especially Japan, import honeysuckle from China to extract antibacterial and antiviral components of chlorogenic acid and isochlorogenic acid, which greatly increase the added value of APIs. In China, in addition to the traditional origin of Shandong, Henan, Sichuan, Chongqing, Guizhou, Jiangsu, and Hunan have all been planted on the scale of honeysuckle in recent years.
Zhang Zhongyi stated that except for primary products such as honeysuckle tea and toothpaste and certain cosmetics produced in a few areas in China, there are mainly sales of bulk drugs, and there are no reports of comprehensive development and application in different fields at the same time, indicating the potential of comprehensive development of honeysuckle flowers. Great.
Market demand has risen steadily. Hubei Wuwu Pharmaceutical Co., Ltd. is a large buyer of honeysuckle. With the use of honeysuckle as the main raw material, the reputation and share of the market are quite high. In the past few months last year, the sales volume of one single product of honeysuckle was close to 300 million yuan, and the annual purchase of honeysuckle was about 2,000 tons.
Chen Weizheng, deputy general manager of the company, said that at present, the honeysuckle purchased from Hubei only accounts for a small part, and a large amount of honeysuckle used in Henan Kaifeng. Local enterprises in Hubei vigorously develop honeysuckle plantations, which should be promising.
As the country's largest private pharmaceutical distribution company, Hubei Jiuzhou Tongmai Co., Ltd. will purchase a large amount of honeysuckle every year. Huang Jianhua, head of procurement of the company's headquarters for traditional Chinese medicine, said that Kyrgyzstan’s annual honeysuckle purchase volume is about 120 tons. Because it is used for traditional Chinese medicine decoction pieces, the requirements for the product phase are very high, and the purchase cost is generally higher than the purchase price on the market. If Hubei local companies improve planting technology and the quality of honeysuckle, the company will also consider increasing the proportion of local honeysuckle purchases in Hubei.
Professor Zhang Yongqing, vice president of the College of Pharmacy of Shandong University of Traditional Chinese Medicine, estimated that the annual demand for honeysuckle in China should be around 20,000 tons. He analyzed that the current planting area of ​​four major producing areas, such as Shandong, Henan, Hebei and Shaanxi, is about 300,000 mu. According to the calculation of 100 kilograms of honeysuckle production per mu, the production capacity is about 30,000 tons, which is in a state of oversupply.
Although Professor Zhang Yongqing’s projected demand and Shi Weidong’s expected demand of around 80,000-100,000 tons are quite different, the two agreed that in the future, with the comprehensive development and utilization of honeysuckle, the demand for honeysuckle will increase significantly. Has a healthy, potential market space.
The prospects are promising but not blindly planted. Yuan Zhiguo, general manager of Jixian Zhiyuan Ecological Agricultural Science and Technology Development Co., Ltd. analyzed that as long as the purchase price stays above 80 yuan per kilogram, the growers still have enthusiasm.
Yuan Zhiguo calculated an account for the reporter: The first year of honeysuckle planting, the second year can be flowering, the third year of high yield, up to more than 100 kilograms per mu. Honeysuckle is picked from May to August. If it is not harvested in time, there will be no medicinal value when it is blossomed. Therefore, an acre of land often requires 2 to 3 hand-picking, and the labor cost is high. The cost per kilogram from picking to drying is around 60 yuan, plus the costs of fertilizers, pesticides and field management. The cost price of honeysuckle is around 80 yuan. Judging from the current market price, the earnings are significant.
Shi Weidong told the reporter that in 2010, Hubei Golden Eagle Agricultural Company introduced 1,300 acres of high-quality tree-type honeysuckle seedlings as a demonstration base in Yangxin County. According to the inspection of products by the Hubei Institute of Drug Control, the content of chlorogenic acid in the active ingredient is 2 times that of the State Pharmacopoeia, and the content of luteolin in another effective ingredient is 1.6 times that of the State Pharmacopoeia. After two years of trial planting, the current output per mu of the demonstration base can reach more than 20 kg. Based on the current market value, the average output value of the mu will reach about 3,200 yuan. According to the growth characteristics of honeysuckle, the fourth year will reach the high yield period, the per mu output will be more than 100 kg, and the per mu output value will reach about 20,000 yuan.
Hubei Shiwai Rural Eco-Agriculture Co., Ltd. Tang Xiong said that the company has 200 acres of demonstration bases for alpine honeysuckle, and it is planned to develop more than 2,000 mu of plants before the end of the year.
Professor Wang Mo, director of the Honeysuckle Institute of Huazhong Agricultural University and director of the Hubei Research Center for Medicinal Plants, believes that the recent fall in the market price of honeysuckle may not be due to sufficient supply or insufficient demand, and the National Development and Reform Commission recently increased the use of Chinese herbal medicines. Regulatory efforts related.
Professor Wang Mo also stated that although everyone is optimistic about the prospect of honeysuckle planting, it cannot be blindly planted. The first is to keep a close eye on market conditions and scientifically view the market fluctuations in the prices of Chinese herbal medicines. Second, while preventing market risks, make full use of Hubei’s scientific and educational resources, adhere to scientific cultivation, and establish high-quality seed-producing bases for honeysuckle to create a brand of Hubei honeysuckle. . (Reporter Lin Tao intern Du Chengjie Yuan Yuzhen)
Earlier, the honeysuckle market has been bullish for two consecutive years and the market price has been on the rise. Many townships and towns in our province regard it as a key industry to adjust the income structure of farmers and give them strong support.
On October 15, the Hubei Honeysuckle Industry Development Seminar was held in Yangxin. Experts at the meeting said that the fall in the price of honeysuckle this time is a return to normal value, and the prospects for planting honeysuckle are still promising.
With comprehensive development potential Honeysuckle is a precious medicinal flower, its flowers, leaves, vines can be used as medicine. In recent years, honeysuckle has been identified by the State Council as one of the 70 kinds of valuable medicinal materials and one of the 38 kinds of precious Chinese medicinal materials that the country has focused on.
According to incomplete statistics, one-third of Chinese herbal formulas require the use of honeysuckle, such as the well-known "Yinqiao Tablets," "Yinhuang Oral Liquid," "Shuanghuanglian," etc., all with honeysuckle as the main raw material.
According to Shi Weidong, deputy general manager of Hubei Golden Eagle Agricultural Development Co., Ltd., honeysuckle has many functions, especially for enhancing immunity, cancer resistance, and regulating fat metabolism. It has become a health food and beverage for Wahaha honeysuckle tea and Wong Lo Kat herbal tea. Important raw materials. The fragrance extracted from honeysuckle has a market price of RMB 750,000 per kilogram. Currently, some companies have achieved initial results in purification technology.
Professor Zhang Chongyi of Henan Agricultural University pointed out that honeysuckle has been listed as the preferred medicine in the prevention and treatment prescriptions for "bird flu" and "hand-foot-mouth disease" in recent years. Many countries, especially Japan, import honeysuckle from China to extract antibacterial and antiviral components of chlorogenic acid and isochlorogenic acid, which greatly increase the added value of APIs. In China, in addition to the traditional origin of Shandong, Henan, Sichuan, Chongqing, Guizhou, Jiangsu, and Hunan have all been planted on the scale of honeysuckle in recent years.
Zhang Zhongyi stated that except for primary products such as honeysuckle tea and toothpaste and certain cosmetics produced in a few areas in China, there are mainly sales of bulk drugs, and there are no reports of comprehensive development and application in different fields at the same time, indicating the potential of comprehensive development of honeysuckle flowers. Great.
Market demand has risen steadily. Hubei Wuwu Pharmaceutical Co., Ltd. is a large buyer of honeysuckle. With the use of honeysuckle as the main raw material, the reputation and share of the market are quite high. In the past few months last year, the sales volume of one single product of honeysuckle was close to 300 million yuan, and the annual purchase of honeysuckle was about 2,000 tons.
Chen Weizheng, deputy general manager of the company, said that at present, the honeysuckle purchased from Hubei only accounts for a small part, and a large amount of honeysuckle used in Henan Kaifeng. Local enterprises in Hubei vigorously develop honeysuckle plantations, which should be promising.
As the country's largest private pharmaceutical distribution company, Hubei Jiuzhou Tongmai Co., Ltd. will purchase a large amount of honeysuckle every year. Huang Jianhua, head of procurement of the company's headquarters for traditional Chinese medicine, said that Kyrgyzstan’s annual honeysuckle purchase volume is about 120 tons. Because it is used for traditional Chinese medicine decoction pieces, the requirements for the product phase are very high, and the purchase cost is generally higher than the purchase price on the market. If Hubei local companies improve planting technology and the quality of honeysuckle, the company will also consider increasing the proportion of local honeysuckle purchases in Hubei.
Professor Zhang Yongqing, vice president of the College of Pharmacy of Shandong University of Traditional Chinese Medicine, estimated that the annual demand for honeysuckle in China should be around 20,000 tons. He analyzed that the current planting area of ​​four major producing areas, such as Shandong, Henan, Hebei and Shaanxi, is about 300,000 mu. According to the calculation of 100 kilograms of honeysuckle production per mu, the production capacity is about 30,000 tons, which is in a state of oversupply.
Although Professor Zhang Yongqing’s projected demand and Shi Weidong’s expected demand of around 80,000-100,000 tons are quite different, the two agreed that in the future, with the comprehensive development and utilization of honeysuckle, the demand for honeysuckle will increase significantly. Has a healthy, potential market space.
The prospects are promising but not blindly planted. Yuan Zhiguo, general manager of Jixian Zhiyuan Ecological Agricultural Science and Technology Development Co., Ltd. analyzed that as long as the purchase price stays above 80 yuan per kilogram, the growers still have enthusiasm.
Yuan Zhiguo calculated an account for the reporter: The first year of honeysuckle planting, the second year can be flowering, the third year of high yield, up to more than 100 kilograms per mu. Honeysuckle is picked from May to August. If it is not harvested in time, there will be no medicinal value when it is blossomed. Therefore, an acre of land often requires 2 to 3 hand-picking, and the labor cost is high. The cost per kilogram from picking to drying is around 60 yuan, plus the costs of fertilizers, pesticides and field management. The cost price of honeysuckle is around 80 yuan. Judging from the current market price, the earnings are significant.
Shi Weidong told the reporter that in 2010, Hubei Golden Eagle Agricultural Company introduced 1,300 acres of high-quality tree-type honeysuckle seedlings as a demonstration base in Yangxin County. According to the inspection of products by the Hubei Institute of Drug Control, the content of chlorogenic acid in the active ingredient is 2 times that of the State Pharmacopoeia, and the content of luteolin in another effective ingredient is 1.6 times that of the State Pharmacopoeia. After two years of trial planting, the current output per mu of the demonstration base can reach more than 20 kg. Based on the current market value, the average output value of the mu will reach about 3,200 yuan. According to the growth characteristics of honeysuckle, the fourth year will reach the high yield period, the per mu output will be more than 100 kg, and the per mu output value will reach about 20,000 yuan.
Hubei Shiwai Rural Eco-Agriculture Co., Ltd. Tang Xiong said that the company has 200 acres of demonstration bases for alpine honeysuckle, and it is planned to develop more than 2,000 mu of plants before the end of the year.
Professor Wang Mo, director of the Honeysuckle Institute of Huazhong Agricultural University and director of the Hubei Research Center for Medicinal Plants, believes that the recent fall in the market price of honeysuckle may not be due to sufficient supply or insufficient demand, and the National Development and Reform Commission recently increased the use of Chinese herbal medicines. Regulatory efforts related.
Professor Wang Mo also stated that although everyone is optimistic about the prospect of honeysuckle planting, it cannot be blindly planted. The first is to keep a close eye on market conditions and scientifically view the market fluctuations in the prices of Chinese herbal medicines. Second, while preventing market risks, make full use of Hubei’s scientific and educational resources, adhere to scientific cultivation, and establish high-quality seed-producing bases for honeysuckle to create a brand of Hubei honeysuckle. . (Reporter Lin Tao intern Du Chengjie Yuan Yuzhen)
Tebipenem,Tebipenem Powder,Tebipenem Side Chain,Tebipenem Intermediate
Xinxiang Haibin Pharmaceutical Co.,Ltd , https://www.carbapenemspharmacy.com